Evidence map›Paper›PMID 39846144›Full record

ArticlePharmaceutical statistics

A Commensurate Prior Model With Random Effects for Survival and Competing Risk Outcomes to Accommodate Historical Controls.

Manoj Khanal, Brent R Logan, Anjishnu Banerjee, Xi Fang, Kwang Woo Ahn

Abstract read
In one paragraph

Article in Pharmaceutical statistics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Manoj KhanalDivision of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Brent R LoganDivision of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Anjishnu BanerjeeDivision of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Xi FangDepartment of Biostatistics, Yale University, New Haven, Connecticut, USA.
Kwang Woo AhnDivision of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.ORCID 0000-0003-4567-8037

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
Blood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc.U24HL138660 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Steven M. DeVine, Mehdi Hussain Hamadani · 2017 to 2026
$71.4M
Clinical and Translational Science AwardUL1TR001436 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI FREED, JULIE K · 2015 to 2025
$47.5M
Easy-to-read Informed Consent for HCT Clinical TrialsU10HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2011 to 2016
$43.8M
HRSA HHS HHSH234200637015CNCATS NIH HHS UL1 TR001436NCATS NIH HHS UL1TR001436NCI NIH HHS U24 CA076518NCI NIH HHS U24CA076518NCI NIH HHS U24HL138660NHLBI NIH HHS U10 HL069294NHLBI NIH HHS U10HL069294NHLBI NIH HHS U24 HL138660
6 · The paper itself

Abstract

Clinical trials (CTs) often suffer from small sample sizes due to limited budgets and patient enrollment challenges. Using historical data for the CT data analysis may boost statistical power and reduce the required sample size. Existing methods on borrowing information from historical data with right-censored outcomes did not consider matching between historical data and CT data to reduce the heterogeneity. In addition, they studied the survival outcome only, not competing risk outcomes. Therefore, we propose a clustering-based commensurate prior model with random effects for both survival and competing risk outcomes that effectively borrows information based on the degree of comparability between historical and CT data. Simulation results show that the proposed method controls type I errors better and has a lower bias than some competing methods. We apply our method to a phase III CT which compares the effectiveness of bone marrow donated from family members with only partially matched bone marrow versus two partially matched cord blood units to treat leukemia and lymphoma.

Indexed as

Clinical Trials, Phase III as TopicModels, StatisticalBone Marrow TransplantationComputer SimulationHumansLeukemiaLymphomaSample SizeSurvival Analysisborrowing from historical datacommensurate priorDirichlet processmatching

Identifiers

PMID39846144
PMCPMC12147052

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.